Sibeprenlimab’s priority review highlights potential to differentiate in IgAN space EP News Bureau May 30, 2025 Interim results showed that sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour…
Otsuka Pharma gets USFDA approval for Brexpiprazole to treat Alzheimer’s agitation Reuters May 12, 2023 Brexpiprazole was previously approved in the US to treat adults with major depressive disorder and schizophrenia
Lupin gets tentative nod from US FDA to market generic Brexpiprazole tablets Press Trust of India Oct 7, 2021 The product is a generic version of Otsuka Pharmaceutical's Rexulti tablets in the same strengths
